Monoclonal Antibodies
According to a new study published in the Proceedings of the National Academy of
Spectrum Pharmaceuticals is reporting results from a randomized study pitting the company's
Spectrum Pharmaceuticals will be presenting five study abstracts related to Zevalin, the company
Spectrum Pharmaceuticals has announced that it intends to acquire the international
Spectrum Pharmaceuticals Inc, the biotech firm that owns and makes the
In case you're unfamiliar, the Rituxan Retirement Plan (RRP) is an inside joke amongst
Convinced by a steady stream of research, the U.K.'s National Institute for Health and Clinical
Rituxan® is the brand marketing name of the monoclonal
Fewer side effects, a lower toxicity profile, and a better treatment outcome—all ideal hopes for
FDA Approves the Removal of the Bioscan Requirement for ZEVALIN® Treatment
HENDERSON,
The U.S. Food and Drug Administration has approved a shorter, 90-minute infusion of rituximab
Bexxar® (tositumomab and iodine I 131 ) is a radiolabled